Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05929235
Title A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Flare Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth RECRUITING Scottsdale Arizona 85258 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06519 United States Details
Mass General Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Icahn School of Medicine at Mount Sinai RECRUITING New York New York 10029 United States Details
Memorial Slone Kettering Cancer Center RECRUITING New York New York 10065 United States Details
UNC Lineberger Comprehensive Cancer Center RECRUITING Chapel Hill North Carolina 27514 United States Details
The Cleveland Clinic Foundation RECRUITING Cleveland Ohio 44195 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
New Experimental Therapeutics of San Antonio (NEXT) RECRUITING San Antonio Texas 78229 United States Details
South Texas Accelerated Research Therapeutics (START) RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field